Search - tctmd.com

Displaying 1 - 20 of 155

Sort: Relevancy | Date

News Conference News ISC 2026

OCEANIC-STROKE: Asundexian Prevents Recurrent Strokes, With No Added Bleeding

Todd Neale

February 09, 2026

News Daily News

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Michael O'Riordan

January 30, 2026

News Conference News AHA 2025

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

Todd Neale

November 08, 2025

News Daily News

Two New Scores Help Hone 10-Year CV Death Risk in ASCVD Patients

Caitlin E. Cox

October 16, 2025

News Daily News

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Caitlin E. Cox

October 03, 2025

News Daily News

Risk Factors Present in Nearly All Patients Who Develop CVD

Michael O'Riordan

October 02, 2025

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Conference News ESC 2025

High hs-CRP Linked to More CVD Events in Women Lacking Traditional Risk Factors

Caitlin E. Cox

August 29, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

No Change in HF Outcomes When Private Equity Buys the Hospital

News Daily News

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Michael O'Riordan

June 16, 2025

News Conference News European Congress on Obesity 2025

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Michael O'Riordan

May 13, 2025

News Daily News

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Michael O'Riordan

March 06, 2025

News Daily News

Danish Analysis Updates Stroke and MI Risks of Contemporary Contraceptives

L.A. McKeown

March 03, 2025

News Daily News

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

Caitlin E. Cox

February 26, 2025

News Daily News

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

L.A. McKeown

February 14, 2025

News Daily News

Use of Secondary CVD Prevention Meds Still Meager Worldwide

Caitlin E. Cox

February 03, 2025

News Daily News

Aspirin Use for Primary Prevention Declining in US: NHANES

Michael O'Riordan

January 24, 2025

News Conference News AHA 2024

US Obesity Epidemic Continues to Skyrocket, With No End in Sight

Michael O'Riordan

November 15, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

Advertisement

OCEANIC-STROKE: Asundexian Prevents Recurrent Strokes, With No Added Bleeding

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

Two New Scores Help Hone 10-Year CV Death Risk in ASCVD Patients

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Risk Factors Present in Nearly All Patients Who Develop CVD

CVD Still the Leading Cause of Death and Disease Globally

High hs-CRP Linked to More CVD Events in Women Lacking Traditional Risk Factors

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Danish Analysis Updates Stroke and MI Risks of Contemporary Contraceptives

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

Use of Secondary CVD Prevention Meds Still Meager Worldwide

Aspirin Use for Primary Prevention Declining in US: NHANES

US Obesity Epidemic Continues to Skyrocket, With No End in Sight

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content